Chris Nolet
CIK 1782814 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$393
Companies
5
Total Filings
23
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVBP | Director | — | $29.98 | — | $0 | 3 | 2026-06-22 |
| JSPRW | Director | 32,500 | $0.01 | $393 | $0 | 5 | 2025-07-03 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 0 | $3.65 | $0 | $0 | 8 | 2025-02-06 |
| POLARITYTE, INC. (PTE) Delisted | Director | 14,403 | $0.24 | $3.5K | $0 | 4 | 2023-01-17 |
| Viela Bio, Inc. (VIE) Delisted | Director | — | — | — | $0 | 2 | 2021-03-15 |
Recent Filings · Page 2 of 3
23 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-13 | JSPRW | Grant (A) | +32,500 | $0 | EDGAR |
| 2022-10-04 | POLARITYTE, INC. (PTE) Delisted | Grant (A) | +50,900 | $0 | EDGAR |
| 2022-05-13 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,059 | $0 | EDGAR |
| 2022-03-23 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +4,013 | $0 | EDGAR |
| 2021-03-15 | Viela Bio, Inc. (VIE) Delisted | Disp (D) | — | $0 | EDGAR |
| 2021-01-05 | POLARITYTE, INC. (PTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-23 | Viela Bio, Inc. (VIE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.